Capsaicin topical
Topical chilli-derived analgesic with modest trial evidence for neuropathic and musculoskeletal pain.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- Low-strength cream: apply to affected area 3–4 times daily
- Time to effect
- Not established
- Safety
- Has documented cautions
Evidence ratings summarise published research on Capsaicin topical in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Capsaicin topical
Interactions
Taking any medication?
Check Capsaicin topical against it.
Why
Capsaicin is the principal pungent compound in chilli pepper (Capsicum frutescens). A BMJ meta-analysis found topical capsaicin better than placebo for chronic neuropathic pain and musculoskeletal pain, but the authors called efficacy moderate to poor, the musculoskeletal benefit was modest (NNT 8.1), and about a third of people had local skin reactions. NICE suggests considering capsaicin cream for localised neuropathic pain when oral treatment is unwanted or not tolerated. The high-strength 8% patch is a prescription-only single-application treatment; its benefit could not be confirmed here, and NICE advises against starting it outside specialist settings.
How it works
Activates and then desensitises TRPV1 receptors on small unmyelinated C-fibre and Aδ-fibre nociceptors, producing initial burning followed by sustained reduction in pain signal transmission. Repeated low-dose application leads to depletion of substance P from cutaneous nerve terminals.
Expected onset · Not established; varies by product and strength
How to take
Dosage
Low-strength cream (0.025–0.075%): apply to affected area 3–4 times daily. High-strength 8% patch (prescription-only): single 30–60 min application by trained clinician, repeatable at ≥3-month intervals.
Timing
Low-strength: 3–4 times daily; high-strength patch: single clinical application
On the label
Low-strength creams (0.025% or 0.075%) with stated capsaicin content. The high-strength 8% patch is prescription-only.
Studied in
Adults with localised neuropathic pain or musculoskeletal pain when oral analgesics are unwanted or not tolerated.
Safety
Evidence
Mason 2004 BMJ meta-analysis of placebo-controlled trials: topical capsaicin gave more people about 50% pain reduction in chronic neuropathic pain (6 trials, n=656; NNT 5.7) and musculoskeletal pain (3 trials, n=368; NNT 8.1). Around one third had local skin reactions. NICE guideline CG173 (2013) suggests considering capsaicin cream for localised neuropathic pain when oral treatment is unwanted or not tolerated.
GRADE certainty: Low — rated by Healicus using the GRADE method
- Derry et al., Cochrane Database Syst Rev 2017, topical capsaicin (high concentration) for chronic neuropathic pain in adults
- Derry & Moore, Cochrane Database Syst Rev 2012, topical capsaicin (low concentration) for chronic neuropathic pain in adults
- Mason et al., BMJ 2004, systematic review of topical capsaicin for the treatment of chronic pain
- NICE guideline (2013): Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)
Questions people ask
Does Capsaicin topical work?
Mason 2004 BMJ meta-analysis of placebo-controlled trials: topical capsaicin gave more people about 50% pain reduction in chronic neuropathic pain (6 trials, n=656; NNT 5.7) and musculoskeletal pain (3 trials, n=368; NNT 8.1). Around one third had local skin reactions. NICE guideline CG173 (2013) suggests considering capsaicin cream for localised neuropathic pain when oral treatment is unwanted or not tolerated. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Capsaicin topical taken?
Low-strength cream (0.025–0.075%): apply to affected area 3–4 times daily. High-strength 8% patch (prescription-only): single 30–60 min application by trained clinician, repeatable at ≥3-month intervals. Timing: Low-strength: 3–4 times daily; high-strength patch: single clinical application. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Initial burning, stinging, erythema are universal. These settle with repeated use. Wash hands thoroughly after application; do not apply near eyes, mucous membranes, or broken skin. High-strength patch requires clinical setting due to acute pain on application. Cough and bronchospasm possible if aerosolised. Pregnancy: avoid high-strength; data on medicinal low-strength use are limited. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Derry et al., Cochrane Database Syst Rev 2017, topical capsaicin (high concentration) for chronic neuropathic pain in adults; Derry & Moore, Cochrane Database Syst Rev 2012, topical capsaicin (low concentration) for chronic neuropathic pain in adults; Mason et al., BMJ 2004, systematic review of topical capsaicin for the treatment of chronic pain; NICE guideline (2013): Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.